HYTN Innovations Cultivates Psilocybin Mushrooms And Upgrades Equipment For API Development
HYTN Innovations Inc. (CSE:HYTN) has successfully initiated cultivation of psilocybin mushrooms under its Dealer’s License granted by Health Canada in accordance with the Controlled Drugs and Substances Act.